scholarly journals Cancer stem cells and their detection using specific cancer stem cell markers- a new strategy for cancer therapies

2021 ◽  
Vol 17 (3) ◽  
pp. 094-099
Author(s):  
Khalida I. Noel ◽  
Rana M. Raoof ◽  
Nibras H. Khamees

Background: In the previous theories of cancer, they considered that cancer was a homogeneous which mean that the tumor had only tumor cells and for this reason the treatment for any tumor directed to kill these tumor cells. But, with rising of the metastatic cases of cancer patients, another theory have been raised, that the cancer is a heterogeneous disease which composed of tumor cells that previously the chemotherapy and other cancer therapies directed toward them, in addition there is another group of cells, called cancer stem cells (CSCs), these are more aggressive than the tumor cells that can force the poor microenvironment of the cancer tissue and survive and also they are undifferentiated cells so can undergo mitosis to produce more tumor cells and another group of cancer stem cells in contrast to the tumor cells, which considered a post mitotic and not divided. Objective: Demonstrate some of cancer stem cell markers that considered an important indicators of early cancer development and lately to detect cases of metastasis. Conclusion: The theory of the presence of cancer stem cells is more acceptable and applicable and so the cancer therapy must be directed to these groups of cancer stem cells.

2013 ◽  
Vol 22 (19) ◽  
pp. 2655-2664 ◽  
Author(s):  
George S. Wilson ◽  
Zenan Hu ◽  
Wei Duan ◽  
Aiping Tian ◽  
Xin M. Wang ◽  
...  

2010 ◽  
Vol 289 (2) ◽  
pp. 208-216 ◽  
Author(s):  
Shaker A. Mousa ◽  
Thangirala Sudha ◽  
Evgeny Dyskin ◽  
Usawadee Dier ◽  
Christine Gallati ◽  
...  

2016 ◽  
Vol 62 (3) ◽  
pp. 228-238 ◽  
Author(s):  
Y.S. Kim ◽  
A.M. Kaidina ◽  
J.H. Chiang ◽  
K.N. Yarygin ◽  
A.Yu. Lupatov

This systematic review aims to analyze molecular markers of cancer stem cells. Only studies that confirmed tumor-initiating capacity of this population by in vivo assay in immunodeficient mice were included. Final sample of papers that fully correspond with initial aim consists of 97 original studies. The results of their analysis reveal that markers commonly used for cancer stem cells deriving were as follows: CD133, СD44, ALDH, CD34, CD24 and EpCAM. The review also contains description of molecular features of some cancer stem cell markers, modern approaches to cancer treatment by targeting this population and brief assessment of cancer stem cell theory development.


PLoS ONE ◽  
2013 ◽  
Vol 8 (1) ◽  
pp. e54579 ◽  
Author(s):  
Sheng-Dong Huang ◽  
Yang Yuan ◽  
Hao Tang ◽  
Xiao-Hong Liu ◽  
Chuan-Gang Fu ◽  
...  

The Prostate ◽  
2011 ◽  
Vol 72 (7) ◽  
pp. 713-720 ◽  
Author(s):  
Marc Colombel ◽  
Colby L. Eaton ◽  
Freddy Hamdy ◽  
Estelle Ricci ◽  
Gabri van der Pluijm ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document